| Bioactivity | Autotaxin-IN-5 (compound 63), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-5 has the potential to treat idiopathic pulmonary fibrosis[1]. |
| Name | Autotaxin-IN-5 |
| CAS | 2156655-99-9 |
| Formula | C30H29N9O2 |
| Molar Mass | 547.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. LEE, Dae Yon, et al. NOVEL COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. WO2018212534A1. |
Autotaxin-IN-5
CAS: 2156655-99-9 F: C30H29N9O2 W: 547.61
Autotaxin-IN-5 (compound 63), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-5 has the po
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.